Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's PEG Ratio or its related term are showing as below:
ISX:DVLA'
s PEG Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.77 Max: 15.88
Current: 15.88
During the past 13 years, PT Darya-Varia Laboratoria Tbk's highest PEG Ratio was 15.88. The lowest was 0.29. And the median was 0.77.
ISX:DVLA's PEG Ratio is ranked worse than 92.53% of 348
companies
in the Drug Manufacturers industry
Industry Median: 1.785
vs ISX:DVLA: 15.88
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
PT Darya-Varia Laboratoria Tbk PEG Ratio Related Terms
PT Darya-Varia Laboratoria Tbk PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's PEG Ratio distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a PEG Ratio of 15.87 as of Jul. 16, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is 1961% above median its historical median of 0.77. Over the past decade, PT Darya-Varia Laboratoria Tbk's PEG Ratio has ranged from 0.29 to 15.88. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #322 out of 348 companies in the Drug Manufacturers industry, placing it in the top 92.5%.
Is PT Darya-Varia Laboratoria Tbk's PEG Ratio too high?
PT Darya-Varia Laboratoria Tbk's current PEG Ratio of 15.87 is 1961% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 15.88. The Drug Manufacturers industry median PEG Ratio is 1.79. PT Darya-Varia Laboratoria Tbk's value of 15.87 is 789.1% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #322 out of 348 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #322 out of 348 companies for PEG Ratio. This places PT Darya-Varia Laboratoria Tbk in the lower half of its industry. The industry median PEG Ratio is 1.79. PT Darya-Varia Laboratoria Tbk's value of 15.87 is 789.1% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own PEG Ratio has ranged from 0.29 to 15.88 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 1.79, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.79, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current PEG Ratio of 15.87 is 789.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current PEG Ratio is 15.87, which is 1961% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,845.60, compared to a current price of Rp1,560.00 — trading 15.5% below its estimated fair value. The current PEG Ratio is 15.87, which is 1961% above median its 10-year median of 0.77 and 789.1% above the Drug Manufacturers industry median of 1.79. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current PEG Ratio is 15.87 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,560.00 is trading 15.5% below its estimated GF Value™ of Rp1,845.60.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
PEG Ratio: 15.87 (1961% above median its 10-year median of 0.77)
GF Value™: Rp1,845.60 vs. price of Rp1,560.00 (15.5% below fair value)
Industry Position: 789.1% above the Drug Manufacturers median (#322 of 348)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score
Get the complete analysis for ISX:DVLA
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
